Rivas Medical Weight Loss

Rivas Medical Weight Loss operates a physician-supervised weight management practice in Glen Burnie, Maryland, where Dr. Rivas oversees clinical protocols centered on GLP-1 receptor agonist therapy for patients struggling with obesity and metabolic dysfunction. The clinic has built a substantial patient base across Maryland, Virginia, and Florida through both in-person consultations at the Glen Burnie office and telehealth appointments, making evidence-based weight loss interventions accessible to patients who may not have local access to peptide-based metabolic care. With a 4.9-star rating across 444 Google reviews, the practice has demonstrated consistent patient satisfaction in a field where outcomes and provider communication are scrutinized closely.

The core therapeutic offerings at Rivas Medical Weight Loss include semaglutide and tirzepatide, two GLP-1 medications that have shown significant efficacy in clinical trials for weight reduction and glycemic control. Semaglutide, a once-weekly subcutaneous injection, works by mimicking the incretin hormone GLP-1 to reduce appetite, slow gastric emptying, and improve insulin secretion in response to meals. Tirzepatide represents a dual GIP/GLP-1 receptor agonist, adding glucose-dependent insulinotropic polypeptide activity to the GLP-1 mechanism, which has demonstrated superior weight loss outcomes in head-to-head studies. Patients at the clinic receive individualized dosing protocols that begin at lower therapeutic doses and titrate upward based on tolerance and response, with Dr. Rivas adjusting treatment plans according to metabolic markers, side effect profiles, and weight loss velocity. The practice does not employ a one-size-fits-all approach; instead, medication selection between semaglutide and tirzepatide depends on patient-specific factors including insurance coverage, prior GLP-1 exposure, diabetes status, and weight loss goals.

Dr. Rivas provides direct medical oversight for all patients enrolled in weight loss programs, conducting initial assessments that include metabolic panels, body composition analysis, and evaluation of contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. The clinic's structured programs integrate prescription peptide therapy with metabolic monitoring through regular follow-up appointments, where patients discuss progress, address side effects like nausea or constipation, and receive adjustments to their pharmacological regimen. Nutritional guidance forms a parallel component of care, with patients receiving education on protein intake targets, meal timing strategies that complement GLP-1-induced satiety, and micronutrient supplementation to prevent deficiencies during caloric restriction. Review patterns indicate that patients appreciate the clinic's non-judgmental approach to weight management, with many noting that their questions about diet modifications, medication mechanisms, and realistic timelines are answered thoroughly during consultations.

Patients initiating treatment at Rivas Medical Weight Loss can expect an onboarding process that begins with a comprehensive health assessment, either in person at the Glen Burnie location or via telehealth for residents of Maryland, Virginia, and Florida. The initial consultation covers medical history review, discussion of previous weight loss attempts, establishment of realistic goals based on starting BMI and comorbidities, and education about how GLP-1 therapies alter hunger signaling and food intake patterns. Patients receive clear information about injection technique, refrigeration requirements for peptide medications, and what to expect during the dose escalation phase when gastrointestinal side effects are most common. Follow-up schedules are established based on individual needs, with most patients checking in monthly during the active weight loss phase to review progress metrics, troubleshoot adherence barriers, and modify the treatment plan as body composition changes. The clinic's high review volume and consistently positive ratings suggest that patients feel supported throughout their treatment course, with accessible communication channels for questions that arise between scheduled appointments.

The availability of telehealth consultations across three states distinguishes Rivas Medical Weight Loss from practices limited to single-state licensure, allowing the clinic to serve patients in suburban and rural areas of Virginia and Florida who lack local access to physicians experienced in peptide-based weight management. This multi-state telemedicine model requires patients to establish care through video consultations, receive prescriptions that can be filled at local pharmacies or through specialized compounding facilities, and complete required laboratory work at convenient locations near their homes. For Maryland residents, the option to choose between in-person visits at the Glen Burnie office and virtual appointments provides flexibility for those with demanding work schedules or mobility limitations. The practice's focus on GLP-1 therapy rather than a broad menu of unrelated aesthetic or wellness services reflects a deliberate clinical specialization, positioning Dr. Rivas as a provider with concentrated expertise in the mechanisms, dosing strategies, and long-term management considerations specific to semaglutide and tirzepatide protocols.